Daeju Meditech Engineering Co., Ltd. is a specialized medical device manufacturer that has accumulated approximately 18 years of technological expertise in the development and production of aesthetic medical devices and beauty equipment, growing primarily through overseas markets. Starting as a sole proprietorship in 2006 and transitioning into a corporation in 2015, the company has secured multiple global regulatory approvals—including CE (Europe), FDA (United States), ANVISA (Brazil), GOST-R (Russia), and SFDA (Saudi Arabia)—and has supplied products to approximately 40 countries worldwide. Based on the trust built in overseas markets, Daeju Meditech Engineering has recently accelerated its entry into the domestic medical device market while strengthening brand recognition.
Following a temporary decline in revenue during the COVID-19 period, Daeju Meditech Engineering achieved a gradual recovery, recording approximately double the revenue of 2019 levels in 2023. The company has continued stable growth in 2024–2025, maintaining annual revenue exceeding KRW 5 billion. These results are evaluated as outcomes of long-term product credibility established in global markets, sustained R&D investment, and accumulated experience in international distribution.
At KIMES 2026, Daeju Meditech Engineering will officially unveil its next-generation flagship HIFU medical device, LUMINA UP. Developed for skin lifting and firmness enhancement, LUMINA UP is characterized by its ability to deliver strong energy output alongside precise procedural control. Equipped with two specialized handpieces, the system enables accurate treatment across both wide and sensitive areas, while multiple cartridge options—dot, linear, and pen types—allow flexible application tailored to treatment purposes and patient conditions.
LUMINA UP is also recognized for providing noticeable firmness improvement immediately after treatment while minimizing post-procedure recovery time. Designed with stability to accommodate all skin types, the system enhances both operational convenience and procedural accuracy for medical professionals in clinical environments. Through this approach, Daeju Meditech Engineering presents a competitive solution within the premium lifting medical device segment.
The company has identified Asia, the Middle East, and Africa as core target markets for its global business expansion. In particular, the Asia-Pacific region is regarded as one of the fastest-growing markets for aesthetic laser and energy-based medical devices after North America, making it a region with strong potential for expanded transactions. Demand for high-value aesthetic medical devices is also increasing in the Middle East and Africa, leading the company to actively pursue strategic partnership expansion in these regions.
Recently, Daeju Meditech Engineering further strengthened its global regulatory capabilities by obtaining FDA certification for its ACTIVO and NOABLE LASER products. Additional country approvals are currently underway, with tangible outcomes expected in the near future. Looking ahead, the company is also considering the development of next-generation solutions incorporating AI-based medical technologies, focusing on enhancing product competitiveness through technological advancement.
Daeju Meditech Engineering views KIMES 2026 as more than a product showcase, positioning it as an opportunity to build substantive business cooperation with global buyers and reinforce brand credibility. Through the exhibition, the company aims to directly present the technological capability and stability of its medical devices—including LUMINA UP—and to contribute to the global expansion of Korean medical devices through the establishment of long-term international partnerships.